Biotechs raised $15 billion less through IPOs in 2022 versus 2021, and 2023 is shaping up just like 2022. The inflation reduction act, with its added uncertainty about the extent of discounts, is a big
Between the effectiveness of today’s job boards and internal employee networks, there are many searches where organizations wonder if they should do the search themselves and save the expense of hiring an outside recruiting firm.
Harvard Business Review reports that “happy people are 31% more productive, have 37% higher sales, and are three times more creative than their peers.” Are you happy at your job, or are you a victim
Americans pay roughly triple what people in the world’s other big economies pay for the same name-brand, on-patent drugs. Yet the six major U.S. pharma firms that provide fairly detailed accounting data reported their profit
McKinsey estimates there are nearly 270 companies working on utilizing artificial intelligence in drug development. There has been a surge in venture capitalists requesting evaluations of AI drug discovery companies over the past five years.
A bad economy won’t stop patients from taking their medications. Does this common wisdom mean the pharmaceutical industry is recession proof? The answer to this question in the past recessions in the early ‘90s, early
